Get started

Rigel Pharmaceuticals, Inc.

No trades
See on Supercharts
Overview
News Ideas Financials Technicals Forecast

RIGL chart

Key stats

Market capitalization
190.063MUSD
Dividends yield (FY)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.14USD
Net income
−58.573MUSD
Revenue
120.242MUSD
Shares float
171.701M
Beta
0.6

About Rigel Pharmaceuticals, Inc.

Sector
Health Technology
CEO
Raul R. Rodriguez
Headquarters
South San Francisco
Website
rigel.com
Employees (FY)
155
Founded
1996
ISIN
US7665596034
Rigel Pharmaceuticals, Inc. operates as a clinical stage biotechnology company. It discovers and develops novel, targeted drugs in the therapeutic areas of immunology, oncology and immune oncology. The firm focuses on intracellular signalling pathways and related targets that are critical to disease mechanisms. The company's products include Tavalisse, Fostamatinib and R835. Rigel Pharmaceuticals was founded by Donald G. Payan, James M. Gower, Thomas A. Raffin, Garry P. Nolan and Ronald B. Garren on June 14, 1996 and is headquartered in South San Francisco, CA.

Ideas

Watchlist 2023-03-07 $OPK $RIGL $WE SPY - flat this morning as we await the second testimonial day for FED chair Powell. There has been lots of opportunity in small caps the past week so shifting focus there, also to avoid the chop that we see in large cap on Fed days. OPK - Opko health sign deal for experimental Epstein-Barr virus
by UnclePennybagss
RIGL - trending upwardsLooking to take an entry at 1.05 if volume and technicals look promising for Monday. A break below $1 would turn this into a bearish play for me. Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) shareholders (or potential shareholders) will be happy to see that the President, Raul Rodriguez, recently boug
by azheng2649
Rigel Pharmaceuticals doing a thing. RIGLNot quite going to Rigel, but showing more and more promise of higher highs in the not so distant future. Looking quite optimal fractally, actually. Fibonacci goals are in green, reversal or invalidation is in red. This post is not financial advice, make your own financial advice or pay a certified
Long
by Rykin_Capital
RIGL LongSMA50/200 as support OBV > OBV Avg34 Williams %R Crossed -80 Entry 3.65 Stop 3 Target 5.5 I am not a PRO trader. I trade option to test my trading plan with small cost. The max Risk of each plan is less than 1% of my account. If you like this idea, please use SIM/Demo account to try it.
Long
by PlanTradePlanMM

See all ideas 

News Flow

Keep readingKeep reading

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating

An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Financials

Performance
Revenue to profit conversion
Earnings
‪0‬

Stock brokers

Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
TradeStation
TradeStation
Featured
Stocks, Crypto, Futures
4.4Very Good
Learn more
Interactive Brokers
Interactive Brokers
Stocks, Futures, Bonds
4.4Very Good
Learn more

See all brokers